Sartorius Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
AZN | AstraZeneca PLC | Outperform |
17
|
£122.64 | £165.99 | 32.70% | 16 | £190.12B |
TMO | Thermo Fisher Scientific | Outperform |
10
|
$573.64 | $591.94 | 8.08% | 1 | $218.97B |
ROG | Roche Holding | Hold |
16
|
CHF222.30 | CHF307.83 | 22.58% | 9 | CHF179.41B |
DHR | Danaher | Outperform |
10
|
$249.55 | $260.33 | 9.17% | 4 | $184.84B |
MRK | Merck KGaA | Outperform |
18
|
154.15€ | 190.06€ | 15.47% | 4 | 67.02€B |
PH | Parker-Hannifin Corp | Outperform |
10
|
$554.91 | $548.76 | 9.57% | 7 | $71.33B |
BDX | Becton Dickinson and Co | Outperform |
9
|
$233.58 | $284.47 | 18.80% | 8 | $67.51B |
A | Agilent Technologies | Outperform |
10
|
$142.80 | $138.82 | 5.74% | 10 | $41.85B |
BIIB | Biogen | Outperform |
10
|
$219.72 | $299.62 | 31.30% | 13 | $31.99B |
BAYN | Bayer | Hold |
5
|
28.48€ | 45.15€ | 5.34% | 4 | 27.97€B |
MTD | Mettler-Toledo International | Hold |
13
|
$1.25k | $1.12k | -2.56% | 0 | $26.80B |
STE | STERIS | Outperform |
13
|
$210.09 | $238.33 | 14.72% | 4 | $20.76B |
ENTG | Entegris | Outperform |
18
|
$130.01 | $116.12 | 13.07% | 11 | $19.60B |
RGEN | Repligen | Outperform |
16
|
$165.50 | $187.18 | 23.87% | 12 | $9.25B |
GETI B | Getinge AB | Outperform |
18
|
kr232.50 | kr226.10 | -1.94% | 3 | kr63.33B |
3355 | Kuriyama Holdings | Outperform |
17
|
¥1.22k | ¥0.00 | 7.41% | 0 | ¥18.46B |